The eye, an intricate organ comprising physical and physiological barriers, poses a
significant challenge for ophthalmic physicians seeking to treat serious ocular diseases …

Transdermal drug delivery is a promising strategy characterized by minor fluctuations in
blood concentrations, few adverse effects, convenience, and excellent patient compliance …

Cancer is a severe disease that results in death in all countries of the world. A nano-based
drug delivery approach is the best alternative, directly targeting cancer tumor cells with …

AMD is the leading cause of blindness and is found in elderly patients. Lutein is a carotenoid
and has antioxidant properties hence acting as a neuroprotective in the macular region …

The complex anatomy and physiological barriers of the eye make delivering ocular
therapeutics challenging. Generally, effective drug delivery to the eye is hindered by rapid …

Fundus neovascularization diseases are a series of blinding eye diseases that seriously
impair vision worldwide. Currently, the means of treating these diseases in clinical practice …

Background: Diabetic Macular Edema (DME) significantly impairs vision in diabetics, with
varied patient responses to current treatments like anti-vascular endothelial growth factor …

Because of their high specificity, high affinity, and targeting, antibody drugs have been
widely used in the treatment of many diseases and have become the most favored new …

There are a number of obstacles that complicate the development of intravitreal delivered
small molecules therapies. One serious complication is the potential need for complex …